We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/5/2018 09:10 | GDPR hitting home hear? Strange I thought that would be a positive. | painter | |
20/5/2018 06:49 | Interesting interview about the recent Medforce acquisition in the USA: Extract: "Medforce is a growing, profitable and cash generative organization that has successfully developed its Center suite of enterprise information management, workflow, and compliance software since 1993. Ideagen has always acquired organizations with strong intellectual property, integrating that IP with our existing product suite. As an example, Medforce’s Center suite of products is used by more than 300 customers globally, supporting business process productivity and legal compliance, and we fully expect to be presented with enhanced cross-sell and integration opportunities going forward, with Medforce’s CommandCenter, ContentCenter and SignCenter of particular interest." | rivaldo | |
18/5/2018 07:33 | Thanks rivaldo,,,,,,,,,,,,a | cheshire man | |
18/5/2018 05:54 | That's an interesting article in Shares Magazine, disclosing the internal 200p share price target and noting that current forecasts could be beaten "by a wide margin". Other useful snippets: GRC "is a $7bn-a-year GRC market yet it remains highly fragmented. Ideagen, which has been around since 1993, wants to act as an industry consolidator as well as driving consistent organic growth." "It aims to double revenue and profit every three years and has met or beaten those targets in the past. For example, in 2015 it reported revenue of £14.4m and £3.6m pre-tax profit. The year to 30 April 2018 is expected to show £36.1m of sales and £9.7m of pre-tax profit. Throughout this growth the company has remained highly cash generative and paid modest dividends. The US is now its number one growth market, as it is the world’s single biggest place for GRC spending. That means accelerating acquisitions growth, such as April’s $8.7m purchase of Medforce, a healthcare compliance business." "The net of regulation red tape and compliance accountability is getting ever tighter around industries and organisations across the world. The next big one is EUwide General Data Protection Regulation (GDPR) which comes into force on 25 May and is the latest in a long list of rules designed to keep us better protected. All this puts UK software supplier Ideagen (IDEA:AIM) in a sweet spot thanks to its wide range of off-the-shelf specialised tools. The Midlands-based company concentrates on what it calls the governance, risk and compliance (GRC) space, providing information management solutions to highly regulated industries. Think healthcare, aviation, banking/finance, complex manufacturing, defence and energy." | rivaldo | |
17/5/2018 16:31 | I bought in at 40p and I think it's topping out. It ranks alongside simlar tech shares but they pay a bigger dividend, which IDEA has to do. IMO DYOR | petewy | |
17/5/2018 14:50 | They tipped it at about 60p and actually said take 50% profits at 90p. For some people that's a good gain. I see what you mean though and like you I "ignored" the recommendation having been in at a much lower price than the original tip. | dixies | |
17/5/2018 12:52 | Dixies, Not so long ago, the same Shares magazine was recommending a sell at circa 90p ! I just ignored them :) | multibagger | |
17/5/2018 11:58 | I am hoping this is a 350-500p stock 5 years out from now. The market is there for them but there is clearly lots of execution risk. The U.S. will be the key no doubt. What I hope doesn't happen is someone buying them!! | leavers | |
17/5/2018 10:59 | Also tipped in Shares mag today: "management aiming for 200p which looks achievable". | dixies | |
17/5/2018 10:47 | Yep, great underlying demand for these shares, though today's news may have contributed: "Ideagen’s quality management software to be rolled out across Falkland Islands’ health and social services 17 May 2018 King Edward VII Memorial Hospital will implement Ideagen’s Q-Pulse software for improved quality control, visibility and efficiency of safety and service levels Ideagen is to work with the Falkland Islands’ Health and Social Services Department to help improve local services for residents and visiting tourists. Based in Stanley – the Islands’ capital – King Edward VII Memorial Hospital is the only dedicated medical facility within the Falklands. The hospital will be rolling out Ideagen’s Q-Pulse software to centralise documentation and data management, while standardising operational processes. Q-Pulse is used by hundreds of healthcare organisations globally and will provide staff working for the Health and Social Services Department with control, visibility and improved continuity when following practices based closely on healthcare standards, which are currently mandatory in the UK. etc" | rivaldo | |
17/5/2018 10:23 | What a lovely start to the day, new highs. | igoe104 | |
16/5/2018 12:25 | some massive sells this afternoon, surely a big buyer gobbling them up. | igoe104 | |
15/5/2018 18:34 | Same again today wanttowin, nearly 1.7 MILLION shares traded. is something brewing in the background ? its certainly unusual activity for this share. | igoe104 | |
11/5/2018 19:36 | Really large trades went through today, over 2 mill volume | wanttowin | |
09/5/2018 16:10 | Just dipped my toe in here and great again to see some familiar names! Hi to Rivaldo, GHF, melody et al. | funkmasterp12 | |
08/5/2018 12:04 | Excellent...yet again. As per my tweet, IDEA @Ideagen_Plc Strong t/s our this morning from Ideagen. Met the new CEO at #Mello2018 & v impressed. Excellent appointment. Snippet from broker confirming strong FCF & 32% EPS growth. Smashing company ✅😁 Broker snippet, Ideagen has announced a positive trading update, detailing full-year performance in line with unchanged expectations. Revenue of £36.1m (£35.9mE) implies 33% headline revenue growth including 11% organic growth, and leading to EBITDA growth of 40% to £11.0m (£11.0mE) – in turn suggesting EPS growth of 32%. Revenue quality continues to develop with the “substantial Kind regards GHF | glasshalfull | |
08/5/2018 11:25 | Nice comment too about doubling revenues and adjusted EBITDA every three years. Techmarketview like the statement and the Board reshuffle. BD came across very well at Mello, and DH should continue to thrive in his new role: "Tuesday 08 May 2018 Ideagen appoints new CEO to drive strategic objectives ideagenA trading update from Ideagen, the AIM-listed specialist in quality, safety, risk, audit and performance management software, shows that firm has grown revenue and adjusted EBITDA for the ninth consecutive year. The company is expecting to report revenue up 33% to c£36m and adjusted EBITDA up 40% to c£11m for the 12 months to the end of April 2018. Organic revenue growth looks set to come in at 11% (Ideagen has been acquisitive, including a purchase made in the US just last month). To sustain the execution of its objective of doubling revenues and adjusted EBITDA every three years, Ideagen is making some adjustments to its leadership structure. Former CEO, David Hornsby, has become Executive Chairman – with a specific remit around strategy, M&A and Investor Relations. Ben Dorks (former Chief Customer Officer) will take Hornsby’s position as CEO – focusing in particular on operational performance, customer acquisition and retention, and product development. Both seem like sensible moves to us, with the Execs playing to their strengths." | rivaldo | |
08/5/2018 06:43 | Never let's us down rivaldo :-) | cheshire man | |
08/5/2018 06:10 | Excellent update as always from IDEA - nicely in line, with revenues slightly ahead of expectations, recurring revenues increasing nicely, and above all a very optimistic short and long-term outlook: "David Hornsby, Executive Chairman: "We are pleased to report that the Group has continued to perform well in delivering another year of high quality earnings growth underpinned by strong cash generation. We continue to grow organically and to increase the percentage of our revenues derived from recurring business. The Group has significant contracted work in progress, a growing base of recurring revenues and a strong pipeline of new business opportunities which provides the Board with confidence for the current year and beyond." | rivaldo | |
01/5/2018 20:06 | Good to hear you all so impressed with the presentation Hopefully onwards and upwards! | gswredland | |
01/5/2018 08:06 | .....and on that basis I have added a few more thia am. | melody9999 | |
30/4/2018 23:02 | Concur with all the Mello 2018 comments. Excellent presentation by David & Ben. Delighted to be invested here. Kind regards GHF | glasshalfull | |
30/4/2018 16:13 | I was there at Mello 2018 too and agree with comments posted. David and Ben Dorks were very approachable and took the time to explain. | multibagger | |
30/4/2018 11:48 | Thirded :o)) Extremely impressive presentation. I also had a good chat with the sales manager at the IDEA stand, who was nicely confident. The amount of detail in those slides re the sales process was truly amazing imo. Very, very professional and thorough. | rivaldo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions